Furthermore, middle-aged 5XFAD mice with advanced AD-like pathology showed robust upregulation of Trem2 in agreement with previous results reported in this and other transgenic AD mouse models (Jiang et al., 2014a; Brendel et al., 2017; Hüttenrauch et al., 2018). This evidence concerns the gene TREM2 and Alzheimer disease.